Oncolytics Announces Collaborators to Present REOLYSIN Preclinical Data at ICOVT

By: via Benzinga
Oncolytics Biotech Inc. ("Oncolytics") (NASDAQ: ONCY) today announced that a series of oral and poster presentations are being made by ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.